Clinical trial
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
NCT00359736 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00359736 |
|---|---|
| Title | Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis |
| Official title | Vasodilator Therapy and Exercise Tolerance in IPF Patients |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alveolitis, Fibrosing, Fibrosis, Pulmonary, Hypertension |
| Intervention type | Drug |
| Interventions | sildenafil |
| Enrollment | 29 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Aug 2, 2006 |
| Last update posted | Nov 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: